Sundrug Co.,Ltd.

Tokyo Stock Exchange 9989.T

Sundrug Co.,Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 0.60

Sundrug Co.,Ltd. Price to Sales Ratio (P/S) is 0.60 on January 14, 2025, a -14.17% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Sundrug Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 0.75 on March 12, 2024, which is 23.36% above the current Price to Sales Ratio (P/S).
Sundrug Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 0.52 on November 20, 2024, which is -13.60% below the current Price to Sales Ratio (P/S).
Sundrug Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.64.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Tokyo Stock Exchange: 9989.T

Sundrug Co.,Ltd.

CEO	Mr. Hiroshi Sadakata
IPO Date	Jan. 4, 2001
Location	Japan
Headquarters	1-38-1, Wakamatsucho
Employees	6,662
Sector	Health Care
Industries Drugstores & Retail Pharmacies Discount Retailers Retail & Wholesale

Description

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.

Key trends

Past 5 years